Why Do the Principals of Cardeation Capital Think Joining Forces Makes Sense for Innovation?
Click the link below to listen: Medtech Talk Podcast hosted by Tom…
We’re seeing a new wave of venture investments in healthtech companies — especially those with strong artifical intelligence and machine learning components. Led by some of the world’s largest biopharma companies and tech-focused venture capitalists, these investments are backing efforts to speed drug discovery, improve tests and treatments, and further medical research. For now, most of the investment is focused in the diagnostics/tools (Dx/Tools) sector.
A Silicon Valley Bank analysis last month found that 44 venture-backed deals raised $2.2 billion between 2015 and the first half of 2017 for Dx/Tools companies that use AI/ML as part of their underlying technology.
Continue reading at: https://venturebeat.com/2017/08/05/investors-bet-big-on-ai-for-health-diagnostics/
Click the link below to listen: Medtech Talk Podcast hosted by Tom…
DALLAS, April 9, 2018 /PRNewswire-USNewswire/ -- Patients battling cardiovascular diseases, and even people hoping…
Livongo Joins American Heart Association’s Center for Health Technology and Innovation to…
GoMo Health is excited to announce that we are joining the American…